BioSpace News Archive

Funding will help LucyTx unlock the secrets of mitochondria to develop novel drugs to treat Parkinson’s disease Lucy Therapeutics, a biotech with a unifying mitochondrial platform, announced it secured funding from The Michael J. Fox Foundation for Parkinson’s Research, the largest nonprofit funder of Parkinson’s disease research.

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines announced that Jorge Gomez will join Moderna as Chief Financial Officer, effective Monday, May 9, 2022.

OMNIVISION, a leading global developer of semiconductor solutions, including advanced digital imaging, analog and touch & display technology, today launched new laryngoscope reference designs that include a range of OMNIVISION products that help improve patient care by providing crisp, clear images for single-use video laryngoscopes.

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, has received FDA clearance for the SCOUT Bx™ Delivery System, the first wire-free breast localization solution that can be deployed at the time of stereotactic or MRI-guided biopsy.

The 2022 Medical Device Excellence Awards program has selected Seno Medical’s Imagio® Breast Imaging System as a GOLD award winner in the Radiological, Imaging, and Electromechanical Devices category.

NeoGenomics, Inc. announced that its liquid biopsy focused subsidiary Inivata Limited has unveiled new data at the American Association for Cancer Research Annual Meeting further demonstrating the potential of its RaDaR assay for the detection of minimal residual disease and recurrence.

At the AACR Annual Meeting 2022, Bruker Corporation launched and exhibited unique and novel capabilities for spatial multiomics, single-cell proteomics, and cell-line, tissue and plasma proteomics cancer research.

Dr Beshiri is an accomplished senior medical device executive with special expertise in developing and implementing diagnostics research for biomarkers and has supported over 900 publications in Cardiology, Infectious Disease, and Oncology.

On April 8th, 2022, VenusP-ValveTM, Venus Medtech’s in-house developed innovative transcatheter pulmonic valve replacement (TPVR) system, received CE marking under the Medical Devices Regulation (MDR) to be marketed in Europe.

POXEL SA (Euronext: POXEL - FR0012432516), is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to PXL770 for the treatment of patients with adrenomyeloneuropathy (AMN), the most common form of X-linked adrenoleukodystrophy (ALD).